WILMINGTON, DE / ACCESSWIRE / March 28, 2023 / Transparency Market Research Inc. - The peripheral vasodilator drugs market size was valued at USD 6.0 Bn in 2022, and it is estimated to expand at a ...
New Orleans, LA - The Vasodilation in the Management of Acute CHF (VMAC) trial is the first large study to show efficacy of nesiritide (Natrecor® - Scios, Inc) when added to standard care, such as ...
Vasodilator therapy can reduce the left ventricular volume and mass and improve left ventricular performance in patients with aortic regurgitation. Accordingly, it has been suggested that such therapy ...
The ability of single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) to stratify risk in octogenarians is poorly defined. The authors identified 439 octogenarians who ...
Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients
Many recent studies have focused on the effects of vasodilating treatment in previously untreated patients with EH; however, despite a sizeable residual cardiovascular risk in patients receiving ...
Vasodilator supplements are designed to enhance blood circulation in the body. They accomplish this by aiding in the relaxation of smooth muscles found within the walls of blood vessels, allowing ...
Katrin Milger, Janine F. Felix, Robert Voswinckel, Natascha Sommer, Oscar H. Franco, Friedrich Grimminger, Frank Reichenberger, Werner Seeger, Hossein A. Ghofrani ...
After a four-week course of the vasodilator hormone relaxin, kidney function and blood flow immediately improved in lab rats genetically altered to model polycystic kidney disease (PKD), a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback